SCHEMBL19846138

SCHEMBL19846138

c1ccc2sc(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.56
▸ NPC1 O15118 7/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ PKM P14618 2/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ APP P05067 6/20 0.55
▸ KDM4E B2RXH2 4/20 0.55
▸ MAPT P10636 3/20 0.55
▸ GLA P06280 2/20 0.55
▸ GAA P10253 2/20 0.55
▸ MMP9 P14780 2/20 0.55
▸ MMP8 P22894 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ MEN1 O00255 2/20 0.51
▸ PAX8 Q06710 1/20 0.51
▸ NOD2 Q9HC29 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ TNF P01375 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939221 1.00 RAB9A (0.56) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL16218052 0.99 RAB9A (0.57) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL23108468 0.94 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL23108790 0.94 RAB9A (0.50) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL15835170 0.93 RAB9A (0.52) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL16218146 0.92 RAB9A (0.49) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL23108442 0.92 RAB9A (0.48) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL16218049 0.92 RAB9A (0.51) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL23097258 0.92 RAB9A (0.48) RAB9ANPC1SMN1; SMN2KMT2APKM
SCHEMBL16218050 0.92 RAB9A (0.51) RAB9ANPC1SMN1; SMN2KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11362283-B2 Organic electroluminescent element LG CHEM, LTD. 2022-06-14 — — US disclosed
US-20180040829-A1 ORGANIC ELECTROLUMINESCENT ELEMENT LG CHEM, LTD. (KR) 2018-02-08 — — US disclosed
US-20180040829-A1 ORGANIC ELECTROLUMINESCENT ELEMENT LG CHEM, LTD. (KR) 2018-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11362283-B2 Organic electroluminescent element NCS1, POU5F1, POU2F1 RAB9A 1656/4885NPC1 3366/4885SMN1; SMN2 4434/4885
US-20180040829-A1 ORGANIC ELECTROLUMINESCENT ELEMENT ALPL, EPCAM, CD99 RAB9A 2450/4885NPC1 3912/4885SMN1; SMN2 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback